BRTHF(BRTHF)
BRTHF
No analyst ratings available
No analyst price targets available for BRTHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $967.05B | $991.73B | $1.02T | $1.08T | $1.11T |
| Low | $951.94B | $991.22B | $1.01T | $1.07T | $1.10T |
| High | $982.16B | $992.23B | $1.03T | $1.09T | $1.12T |
| EBITDA Avg | $127.55B | $130.81B | $134.67B | $142.88B | $146.90B |
| Low | $125.56B | $130.74B | $133.59B | $141.75B | $145.73B |
| High | $129.55B | $130.88B | $135.74B | $144.02B | $148.07B |
| EBIT Avg | $84.06B | $86.20B | $88.75B | $94.16B | $96.81B |
| Low | $82.75B | $86.16B | $88.04B | $93.41B | $96.04B |
| High | $85.37B | $86.25B | $89.45B | $94.91B | $97.58B |
| Net Income Avg | $82.86B | $77.62B | $81.93B | $99.76B | $107.69B |
| Low | $82.00B | $76.82B | $81.08B | $98.73B | $106.57B |
| High | $83.72B | $78.43B | $82.78B | $100.80B | $108.81B |
| EPS Avg | $327.72 | $307.02 | $324.04 | $394.58 | $425.93 |
| Low | $324.32 | $303.83 | $320.68 | $390.49 | $421.52 |
| High | $331.12 | $310.20 | $327.39 | $398.67 | $430.35 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $238.19B | $252.80B | $246.58B |
| Low | $234.65B | $250.99B | $244.81B |
| High | $241.73B | $254.61B | $248.34B |
| EBITDA Avg | $31.42B | $33.34B | $32.52B |
| Low | $30.95B | $33.11B | $32.29B |
| High | $31.88B | $33.58B | $32.76B |
| EBIT Avg | $20.70B | $21.97B | $21.43B |
| Low | $20.40B | $21.82B | $21.28B |
| High | $21.01B | $22.13B | $21.59B |
| Net Income Avg | $17.66B | — | — |
| Low | $17.50B | — | — |
| High | $17.82B | — | — |
| EPS Avg | $70.62 | — | — |
| Low | $69.97 | — | — |
| High | $71.28 | — | — |
| Analysts (Rev / EPS) | 2 / 1 | 1 / — | 1 / — |